Halovate Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Halobetasol propionate

Indications/Uses

Relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses.

Click to view Halovate detailed prescribing information

Dosage/Direction for Use

Apply a thin layer into the affected area once daily or bid. Limit treatment to 2 wk. Max: 50 g/wk.

Click to view Halovate detailed prescribing information

Overdosage

View Halovate overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Skin TB, chicken pox, herpes simplex, measles, vaccinia, perioral dermatitis, acne rosacea, syphilitic skin lesions & untreated bacterial, fungal, or viral skin lesions. Not recommended for acne vulgaris. Not recommended in childn <12 yr.

Click to view Halovate detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Halovate detailed prescribing information

Special Precautions

Not for ophth, oral or intravag use. Do not use w/ occlusive dressings. Do not use in the treatment of rosacea or perioral dermatitis, & on the face, groin, or in the axillae. Avoid contact w/ eyes. Discontinue use & institute appropriate therapy if irritation develops. Systemic absorption can produce reversible hypothalamic-pituitary-adrenal axis suppression w/ potential for glucocorticosteroid insufficiency after w/drawal of treatment; manifestations of Cushing's syndrome, hyperglycemia, & glucosuria while on treatment. Use appropriate antifungal or antibacterial agent if concomitant skin infections are present or develop. Do not use extensively, in large amounts, or for protracted periods in pregnant patients or in patients who are planning to become pregnant. Caution when administering to a nursing woman.

Click to view Halovate detailed prescribing information

Use In Pregnancy & Lactation

Click to view Halovate detailed prescribing information

Adverse Reactions

Stinging, burning, itching.

Click to view Halovate detailed prescribing information

Storage

View Halovate storage conditions for details to ensure optimal shelf-life.

Description

View Halovate description for details of the chemical structure and excipients (inactive components).

Action

View Halovate mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Topical Corticosteroids

ATC Classification

D07A - CORTICOSTEROIDS, PLAIN ; Used in the treatment of dermatological diseases.

Regulatory Classification

Patient Counseling Information

View Halovate patient counselling information

Presentation/Packing

Form

Halovate cream 0.5 mg/g

Packing/Price

30 g x 1's (P1,292/tube)

Form

Halovate oint 0.5 mg/g

Packing/Price

30 g x 1's (P1,231/tube)

Halovate

Manufacturer:

Glenmark

Distributor:

Glenmark